A Focus on Life Sciences
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
According to a report published by Cambridge Associates LLC, private equity and venture capital funds in the U.S. continued to generate positive returns for their…
Posted by
The IPO Task Force unveiled a new effort to ease the IPO road for emerging companies in its report, “Rebuilding the IPO On-Ramp.” The report…
Posted by
It’s the biggest question in our “New Normal” economy—how do you build a successful business during a global recession? Despite the lack of any discernable…
Posted by
As another week draws to a close, we’d like to take a minute to look at some developments making their way around the Web and…
Posted by
Safeguard Scientifics announced today that it has signed a definitive agreement to acquire a 36% ownership interest in Penn Mezzanine, a mezzanine platform which commenced operations…
Posted by
More IPO buzz this week. On Wednesday, its first day of trading, Pandora shares were as high as $26. The excitement dwindled a bit on…
Posted by
The last few years have reminded us that the world remains fraught with risk. Business managers came to believe there was no end in sight…
Posted by